BRD4770 2 mg | 99.82%
TargetMol
BRD4770 is a histone methyltransferase G9a inhibitor and induces cell senescence.
More Information Supplier PageBRD4770
Search Results
K02288 100 mg | 99.27%
TargetMol
K02288
K02288 2 mg | 99.27%
TargetMol
K02288
BAY 11-7082 200 mg | 97.91%
TargetMol
BAY 11-7082, a NF-κB inhibitor, inhibits TNFα-induced IκBα phosphorylation. BAY 11-7082 inhibits ubiquitin-specific protease USP7 and USP21.
More Information Supplier PageBAY 11-7082
BAY 11-7082 25 mg | 97.91%
TargetMol
BAY 11-7082, a NF-κB inhibitor, inhibits TNFα-induced IκBα phosphorylation. BAY 11-7082 inhibits ubiquitin-specific protease USP7 and USP21.
More Information Supplier PageBAY 11-7082
H-ASP-PHE-OH 100 mg | Purity Not Available
TargetMol
Rosuvastatin 200 mg | 99.80%
TargetMol
Rosuvastatin is an antilipemic agent that competitively inhibits hydroxymethyl-glutaryl-coenzyme A (HMG-CoA) reductase. HMG-CoA reductase catalyzes the conversion of HMG-CoA to mevalonic acid, the rate-limiting step in cholesterol biosynthesis. Rosuvastatin belongs to a class of medications called statins and is used to reduce plasma cholesterol levels and prevent cardiovascular disease.
More Information Supplier PageRosuvastatin
Rosuvastatin 25 mg | 99.80%
TargetMol
Rosuvastatin is an antilipemic agent that competitively inhibits hydroxymethyl-glutaryl-coenzyme A (HMG-CoA) reductase. HMG-CoA reductase catalyzes the conversion of HMG-CoA to mevalonic acid, the rate-limiting step in cholesterol biosynthesis. Rosuvastatin belongs to a class of medications called statins and is used to reduce plasma cholesterol levels and prevent cardiovascular disease.
More Information Supplier PageRosuvastatin
Rosuvastatin 5 mg | 99.80%
TargetMol
Rosuvastatin is an antilipemic agent that competitively inhibits hydroxymethyl-glutaryl-coenzyme A (HMG-CoA) reductase. HMG-CoA reductase catalyzes the conversion of HMG-CoA to mevalonic acid, the rate-limiting step in cholesterol biosynthesis. Rosuvastatin belongs to a class of medications called statins and is used to reduce plasma cholesterol levels and prevent cardiovascular disease.
More Information Supplier PageRosuvastatin
Mirabegron 10 mg | 99.14%
TargetMol
Mirabegron is a beta-3 adrenergic agonist that is used for treatment of overactive bladder syndrome.
More Information Supplier PageMirabegron
